Drugs in Dev. Hepatology (Liver, Pancreatic, Gall Bladder)
Discovery Platform
United Kingdom 
Lead Product(s) : Undisclosed
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Discovery Platform
Sponsor : GSK
Deal Size : $37.5 million
Deal Type : Licensing Agreement
GSK Enters Multi-Year Data Licence Agreement with Ochre Bio for Liver Disease Research
Details : Ochre and GSK will create a foundational liver biology dataset that could have the potential to further improve translation of novel therapies for liver diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 06, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Discovery Platform
Sponsor : GSK
Deal Size : $37.5 million
Deal Type : Licensing Agreement
Lead Product(s) : Undisclosed
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Discovery Platform
Sponsor : Takeda Pharmaceutical
Deal Size : $500.0 million
Deal Type : Collaboration
Details : Under the terms of the agreement, Takeda will have exclusive rights to develop and commercialise clinical candidates generated against validated targets derived from the collaboration.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 25, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Discovery Platform
Sponsor : Takeda Pharmaceutical
Deal Size : $500.0 million
Deal Type : Collaboration
Reset All
